Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Implementing a Paperless Trial for Phase 3: A Biotech's Lessons Learned
Track : Track 07: Processes and Technologies for Clinical Research
Program Code: 423
Date: Thursday, June 27, 2013
Time: 10:45 AM to 12:15 PM  EST
Location: 252AB
CHAIR :
 Mary R. Flack, (SCHNON), Vice President, Clinical Research, NanoBio Corporation, United States
SPEAKER (S):
 Evonne Roberts, (SPKNON), Director, Business Development, assisTek, United States
 Penelope K. Manasco, MD,MS (SPKNON), CEO, MANA Consulting, United States
Description
This session will discuss how a small biotech implemented a paperless trial for a phase 3 trial using electronic source, eTMF, IVR, and a reporting tool to "integrate" all the data.

Session Recording
(Code: 423)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON5 Comp Access: Thursday Online Access Package - June 27, 2013
Handout Online
(Code: 423)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON5 Comp Access: Thursday Online Access Package - June 27, 2013
Implementing a Paperless Trial for Phase 3: A Biotech's Lessons Learned